CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Friday reported a loss of $15.7 million in its third quarter.
On a per-share basis, the Chicago-based company said it had a loss of 11 cents. Losses, adjusted for non-recurring costs, came to 6 cents per share.
The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of 9 cents per share.
The company posted revenue of $54.3 million in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $51.6 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
